Dyne Therapeutics, Inc. — Director's Dealing 2021

Jul 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dyne Therapeutics, Inc. (DYN)
CIK: 0001818794
Period of Report: 2021-07-10

Reporting Person: McNeill Jonathan (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-10	Stock Option (right to buy)	$21.01	A	25000	Acquired	2031-07-09	Common Stock (25000)	Direct

Footnotes

F1: This option was granted on July 10, 2021. The shares underlying the option are scheduled to vest over four years in equal quarterly installments from July 1, 2021.